- Abstract
- Keywords
- Introduction
- Chemistry of BD
- Antineoplastic effects of BD in human malignancies
- Anti-metastatic effects of BD
- Potential anti-inflammatory effects of BD
- Pharmacokinetics, toxicity and metabolism
- Clinical application of BD
- Conclusion and future directions
- Abbreviations
- Declarations
- References
-
Citing Article List
The journal uses Crossref Cited-by service counts times cited of published articles. Cited-by allows Crossref members to find out who is citing their content. This is the Citing Article List of “Physical characteristics comparison between maytansinoid-based and auristatin-based antibody-drug conjugates”.No. Publication Date Citing Article 1 2022 Yuichi Nakahara, Brian A. Mendelsohn, Yutaka Matsuda. Antibody–Drug Conjugate Synthesis Using Continuous Flow Microreactor Technology, Organic Process Research & Development. 2022; 26: 2766. https://doi.org/10.1021/acs.oprd.2c00217 2 2023 Tomohiro Fujii, Yutaka Matsuda, Takuya Seki, Natsuki Shikida, Yusuke Iwai, Yuri Ooba, Kazutoshi Takahashi, Muneki Isokawa, Sayaka Kawaguchi, Noriko Hatada, Tomohiro Watanabe, Rika Takasugi, Akira Nakayama, Kazutaka Shimbo, Brian A. Mendelsohn, Tatsuya Okuzumi, Kei Yamada. AJICAP Second Generation: Improved Chemical Site-Specific Conjugation Technology for Antibody–Drug Conjugate Production, Bioconjugate Chemistry. 2023; acs.bioconjchem.3c00040. https://doi.org/10.1021/acs.bioconjchem.3c00040 3 2023 Tomohiro Watanabe, Tomohiro Fujii, Jason T. Stofleth, Rika Takasugi, Kazutoshi Takahashi, Yutaka Matsuda. Scale-Up Synthesis of Site-Specific Antibody–Drug Conjugates Using AJICAP Second-Generation Technology, Organic Process Research & Development. 2023; 27: 1136. https://doi.org/10.1021/acs.oprd.3c00111 -
